Skip to main content

DEARBORN, Michigan, March 30, 2020 – Ford Motor Company, in collaboration with GE Healthcare, announced today it will begin producing third-party ventilators. The goal is to produce 50,000 vitally needed units within 100 days and up to 30,000 a month thereafter as needed.

Ford will provide its manufacturing capabilities to quickly scale production. GE Healthcare will provide its clinical expertise and will license the current ventilator design from Airon Corp.Β  This is a small, privately held company specializing in high-tech pneumatic life support products. GE Healthcare brought the Airon Corp. design to Ford’s attention as part of the company’s efforts to quickly scale production of ventilators to help clinicians treat COVID-19 patients.

Ventilators Without The Need For Electricity

GE/Airon Model A-E ventilators uses a design that operates on air pressure without the need for electricity. This will address the needs of most COVID-19 patients. Its production could be quickly scaled up to help meet growing demand in the U.S.

  • With the full weight of the UAW behind the venture and the full power of Ford and GE Healthcare, production of the GE/Airon Model A-E ventilator is targeted to start the week of April 20 at Ford’s Rawsonville (Mich.) Components Plant
  • Ford expects to produce 50,000 ventilators within the next 100 days, with the ability to produce 30,000 a month thereafter as needed
  • The simplified ventilator design – licensed by GE Healthcare from Florida-based Airon Corp. – is responsive to the needs of most COVID-19 patients, and operates on air pressure without the need for electricity
  • This unique, go-fast initiative comes in addition to the previously announced program by Ford and GE Healthcare to increase production capacity of existing GE Healthcare ventilators

 

Ventilators

Working Creatively in Collaboration

“The Ford and GE Healthcare teams, working creatively and tirelessly, have found a way to produce this vitally needed ventilator quickly and in meaningful numbers,” said Jim Hackett, Ford’s president and CEO. “By producing this ventilator in Michigan, in strong partnership with the UAW, we can help health care workers save lives, and that’s our No. 1 priority.

According to White House Defense Production Act Coordinator Peter Navarro, “the Ford/GE Healthcare team is moving’ to speed urgently needed ventilators. Just as Ford in the last century moved its manufacturing might seamlessly from auto to tank production during World War II, the Ford team is working with GE Healthcare to use its awesome engineering and manufacturing capabilities to voluntarily help this nation solve one of its most pressing problems.”

Meeting the Goal of 100 000 Ventilators

Ford will initially send a team to work with Airon to boost production at Florida.By the week of April 20. Then will start production at Ford’s Rawsonville Components Plant in Ypsilanti, Michigan, quickly ramping up to reach full production to help meet surging demand.

Ford expects to produce 1,500Β  ventilators by the end of April, 12,000 by the end of May and 50,000 by July 4. This will help the U.S. government meet its goal of producing 100,000 ventilators in 100 days.

A Ford Tradition

Ford’s Rawsonville plant will produce ventilators nearly around the clock, with 500 paid volunteer UAW-represented employees working on three shifts. Airon currently produces three Airon pNeuton Model A ventilators per day in Melbourne, Fla. In full production, Ford plans to make 7,200 Airon-licensed Model A-E ventilators per week.

“From the days of Rosie the Riveter, UAW members have stepped up during difficult times in this nation’s history for the good of us all,” said UAW International President Rory Gamble. “Today’s announcement by Ford that UAW employees will be made ventilators in Rawsonville is part of that tradition. We are working very closely with Ford to make sure that all CDC guidelines are followed and that we are exercising an abundance of caution inside the plant. Ford and our UAW Ford members should be commended for stepping up in these very uncertain times.”

Ventilators Simplified

“We applaud Ford for its efforts to lend its manufacturing capabilities to help quickly scale the Airon-licensed Model A-E ventilator and arm clinicians in the fight against COVID-19,” said GE Healthcare President and CEO Kieran Murphy. “Our deep understanding of the health care industry with Ford’s supply chain and production expertise will help meet the unprecedented demand for medical equipment. We continue to be encouraged by how quickly companies are coming together in innovative ways to address this collective challenge.”

Collaborative Covid-19 Response

GE Healthcare and Ford consulted with medical experts in determining the Airon-licensedΒ  Model A-E ventilator is well suited for COVID-19 patient care. The design is expected to meet the needs of most COVID-19 patients with respiratory failure or difficulty breathing. The ventilators are designed for quick set-up, making it easy for healthcare workers to use – and can be deployed in an emergency room setting, during special procedures or in an intensive care unit, wherever the patient may be located.

During the COVID-19 Pandemic, LongevityLive.com will be sharing news freely as it comes to hand that’s in the public’s interest.Β  We hope this will help win the war against this virus.

Read more from the Cleveland Clinic on COVID-19 here.

Guest Writer

Guest Writer

This post has been curated by a Longevity Live editor for the website.

Longevity Live is a digital publisher AND DOES NOT OFFER PERSONAL HEALTH OR MEDICAL ADVICE. IF YOU’RE FACING A MEDICAL EMERGENCY, CALL YOUR LOCAL EMERGENCY SERVICES IMMEDIATELY, OR VISIT THE NEAREST EMERGENCY ROOM OR URGENT CARE CENTER. YOU SHOULD CONSULT YOUR HEALTHCARE PROVIDER BEFORE STARTING ANY NUTRITION, DIET, EXERCISE, FITNESS, MEDICAL, OR WELLNESS PROGRAM.

This content, developed through collaboration with licensed medical professionals and external contributors, including text, graphics, images, and other material contained on the website, apps, newsletter, and products (β€œContent”), is general in nature and for informational purposes only and does not constitute medical advice; the Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.

Longevity Live makes no guarantees about the efficacy or safety of products or treatments described in any of our posts. Any information on supplements, related services and drug information contained in our posts are subject to change and are not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

Longevity does not recommend or endorse any specific test, clinician, clinical care provider, product, procedure, opinion, service, or other information that may be mentioned on Longevity’s websites, apps, and Content.